H.R. 8289 · 117th Congress
Banning Misleading Drug Ads Act of 2022
- Stage
- In committee
- Sponsor
- Abigail Spanberger
- Introduced
- 2022-07-05
- Latest action
- 2022-07-05 · Introduced in House
Summary
Banning Misleading Drug Ads Act of 2022
This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)